Posts

Showing posts from April, 2021

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment - Onal - - The Prostate - Wiley Online Library

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment - Onal - - The Prostate - Wiley Online Library

225Ac‐PSMA‐617‐targeted alpha therapy for the treatment of metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis - Ballal - - The Prostate - Wiley Online Library

225Ac‐PSMA‐617‐targeted alpha therapy for the treatment of metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis - Ballal - - The Prostate - Wiley Online Library

OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL - ScienceDirect

OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL - ScienceDirect

Understanding the Importance of Radiopharmaceutical Scans and Why They Might Not Be Available for Us When We Need Them

Understanding the Importance of Radiopharmaceutical Scans and Why They Might Not Be Available for Us When We Need Them

A revolutionary advance in patient-centric prostate cancer advocacy/support | THE "NEW" PROSTATE CANCER INFOLINK

A revolutionary advance in patient-centric prostate cancer advocacy/support | THE "NEW" PROSTATE CANCER INFOLINK prostatecancerinfolink.net A revolutionary advance in patient-centric prostate cancer advocacy/support 6-8 minutes For those who have not already heard about it, two of the very largest patient-centric prostate cancer advocacy organizations have agreed to merge into one. ZERO — The End of Prostate Cancer and Us TOO International to Merge to Better Serve the Prostate Cancer Community New unified organization is a major win for prostate cancer patients, survivors, families, and medical professionals Washington, D.C. – April 22, 2021 – The prostate cancer community will have a new patient-centric powerhouse in its corner with the coming merger of ZERO – The End of Prostate Cancer and Us TOO International. The unification of these two leading prostate cancer organizati

OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL - International Journal of Radiation Oncology, Biology, Physics

OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL - International Journal of Radiation Oncology, Biology, Physics

Einstein Researchers Develop Novel Drug That Regenerates Erectile Nerves Damaged by Prostate Surgery | Newsroom | Albert Einstein College of Medicine

Image
Einstein Researchers Develop Novel Drug That Regenerates Erectile Nerves Damaged by Prostate Surgery | Newsroom | Albert Einstein College of Medicine einsteinmed.org Einstein Researchers Develop Novel Drug That Regenerates Erectile Nerves Damaged by Prostate Surgery | Albert Einstein College of Medicine 6-8 minutes April 19, 2021—(BRONX, NY)— Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today in JCI Insight . These images show neurons cultured in petri dishes and treated with either control (inactive) siRNA (left) or the siRNA drug itself (FL2 siRNA) (right). Neurons treated with the drug regenerate the

What is active surveillance for prostate cancer? | MD Anderson Cancer Center

What is active surveillance for prostate cancer? | MD Anderson Cancer Center

Late ADT a Problem in Prostate Cancer | MedPage Today

Late ADT a Problem in Prostate Cancer | MedPage Today

FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging - ScienceDirect

FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging - ScienceDirect

No More Men Need to Die From Transrectal Prostate Biopsies | MedPage Today

No More Men Need to Die From Transrectal Prostate Biopsies | MedPage Today

Start With All the Little Things | Humanities | JAMA | JAMA Network

Start With All the Little Things | Humanities | JAMA | JAMA Network

Novel drug regenerates erectile nerves damaged by prostate surgery -- ScienceDaily

Novel drug regenerates erectile nerves damaged by prostate surgery -- ScienceDaily

Personalized cancer vaccine deemed safe, shows potential benefit against cancer -- ScienceDaily

Personalized cancer vaccine deemed safe, shows potential benefit against cancer -- ScienceDaily

Healthy Lifestyle May Offset Genetic Risk in Prostate Cancer

Healthy Lifestyle May Offset Genetic Risk in Prostate Cancer

Mixed Results for Immunotherapy in Metastatic Prostate Cancer | MedPage Today

Mixed Results for Immunotherapy in Metastatic Prostate Cancer | MedPage Today

Body weight, fat mass and metabolic complications during androgen deprivation therapy: should urologists recommend exercise and diet to help patients overcome toxicities? | Prostate Cancer and Prostatic Diseases

Body weight, fat mass and metabolic complications during androgen deprivation therapy: should urologists recommend exercise and diet to help patients overcome toxicities? | Prostate Cancer and Prostatic Diseases

Novel Genomic Alterations in Circulating Tumor Cells Tied to Castrate-Resistant Prostate Cancer

Novel Genomic Alterations in Circulating Tumor Cells Tied to Castrate-Resistant Prostate Cancer

More Benefit With Taxane for Aggressive Metastatic Prostate Cancer | MedPage Today

More Benefit With Taxane for Aggressive Metastatic Prostate Cancer | MedPage Today

Long Term Outcomes of Dose Escalated Pelvic Lymph Node Intensity Modulated Radiation Therapy (IMRT) with A Simultaneous Hypofractionated Boost to the Prostate For Very High Risk Adenocarcinoma of the Prostate, a Prospective Phase II Clinical Trial - ScienceDirect

Long Term Outcomes of Dose Escalated Pelvic Lymph Node Intensity Modulated Radiation Therapy (IMRT) with A Simultaneous Hypofractionated Boost to the Prostate For Very High Risk Adenocarcinoma of the Prostate, a Prospective Phase II Clinical Trial - ScienceDirect

BRCA2 Mutations and Immunotherapy - Improved outcomes with Checkpoint Inhibitors — Cancer ABCs

BRCA2 Mutations and Immunotherapy - Improved outcomes with Checkpoint Inhibitors — Cancer ABCs

Importance of radiotherapy to the primary in metastatic hormone sensitive prostate cancer | Prostate Cancer and Prostatic Diseases

Importance of radiotherapy to the primary in metastatic hormone sensitive prostate cancer | Prostate Cancer and Prostatic Diseases

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study | Prostate Cancer and Prostatic Diseases

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study | Prostate Cancer and Prostatic Diseases

The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy - Wang - - The Prostate - Wiley Online Library

The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy - Wang - - The Prostate - Wiley Online Library

Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer | Prostate Cancer and Prostatic Diseases

Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer | Prostate Cancer and Prostatic Diseases

Quality of life in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases

Quality of life in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases

Psychological interventions in prostate cancer: a farewell to mind–body dualism | Prostate Cancer and Prostatic Diseases

Psychological interventions in prostate cancer: a farewell to mind–body dualism | Prostate Cancer and Prostatic Diseases

Minimizing the risk of sarcopenic obesity during androgen deprivation therapy—promising results for men treated with GnRH antagonists | Prostate Cancer and Prostatic Diseases

Minimizing the risk of sarcopenic obesity during androgen deprivation therapy—promising results for men treated with GnRH antagonists | Prostate Cancer and Prostatic Diseases

How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer | Prostate Cancer and Prostatic Diseases

How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer | Prostate Cancer and Prostatic Diseases

An emerging treatment option for men with recurring prostate cancer after radiation therapy - Harvard Health Blog - Harvard Health Publishing

An emerging treatment option for men with recurring prostate cancer after radiation therapy - Harvard Health Blog - Harvard Health Publishing health.harvard.edu An emerging treatment option for men with recurring prostate cancer after radiation therapy - Harvard Health Blog Charlie Schmidt 5-6 minutes Prostate cancer is often a multifocal disease, meaning that several tumors can be present in different parts of gland at the same time. Not all of these tumors are equally problematic, however. And it’s increasingly thought that the tumor with the most aggressive features — called the index lesion — dictates how a man’s cancer is likely to behave overall. That concept has given rise to a new treatment option. Called partial gland ablation (PGA), and also focal therapy, it entails treating only the index lesion and its surrounding tissues, instead

Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer | Cancer Epidemiology, Biomarkers & Prevention

Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer | Cancer Epidemiology, Biomarkers & Prevention

Top UK brain surgeon calls for urgent inquiry into assisted dying | Assisted dying | The Guardian

Top UK brain surgeon calls for urgent inquiry into assisted dying | Assisted dying | The Guardian theguardian.com Top UK brain surgeon calls for urgent inquiry into assisted dying Harriet Sherwood 4-5 minutes Henry Marsh, one of the UK’s leading brain surgeons and a bestselling author, has called for an urgent inquiry into assisted dying after revealing he has advanced prostate cancer. Marsh, the author of Do No Harm: Stories of Life, Death and Brain Surgery , said dying of cancer could be “a very horrible business” but the law “insists I must suffer”. Politicians had “shown a striking lack of compassion by ducking this issue for too long and are inadvertently guilty of great cruelty”, he said. His call for an inquiry is backed by more than 50 MPs and peers from different parties, some of whom have previously voted against changing the law. Their letter to Robert Buckland, the justice se

Are we closer to automated pathological assessment of prostate cancer biopsy slides? | THE "NEW" PROSTATE CANCER INFOLINK

Are we closer to automated pathological assessment of prostate cancer biopsy slides? | THE "NEW" PROSTATE CANCER INFOLINK